Evidence map›Paper›PMID 30763662›Full record

ArticleInternational journal of radiation oncology, biology, physics2019

Endothelial Cell-Derived Extracellular Vesicles Mitigate Radiation-Induced Hematopoietic Injury.

Sadhna O Piryani, Yiqun Jiao, Angel Y F Kam, Yang Liu, Tuan Vo-Dinh, Benny J Chen, Nelson J Chao, Phuong L Doan

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Cell Therapies for Acute Radiation Syndrome.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  12. Review
  13. Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sadhna O PiryaniDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
Yiqun JiaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
Angel Y F KamDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
Yang LiuDepartment of Biomedical Engineering, Duke University, Durham, North Carolina; Department of Biomedical Engineering Chemistry, Duke University, Durham, North Carolina.
Tuan Vo-DinhDepartment of Biomedical Engineering, Duke University, Durham, North Carolina; Department of Biomedical Engineering Chemistry, Duke University, Durham, North Carolina.
Benny J ChenDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina.
Nelson J ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina.
Phuong L DoanDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina; Duke Cancer Institute, Duke University, Durham, North Carolina. Electronic address: phuong.doan@duke.edu.
Duke University · USDuke Medical Center · US

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
Somatostatin analogues as countermeasures against intestinal radiation toxicityU19AI067798 · NIAID · DUKE UNIVERSITY · PI CHAO, NELSON J. · 2005 to 2024
$82.1M
Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fateK08CA184552 · NCI · DUKE UNIVERSITY · PI DOAN, PHUONG LINH · 2014 to 2018
$639k
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
NCI NIH HHS K08 CA184552NIAID NIH HHS U19 AI067773NIAID NIH HHS U19 AI067798NIAID NIH HHS UC6 AI058607NIH HHS S10 OD018164
6 · The paper itself

Abstract

purposeExtracellular vesicles (EVs) are shed vesicles that bear a combination of nucleic acids and proteins. EVs are becoming recognized as a mode of cell-to-cell communication. Because hematopoietic stem cells reside in proximity to endothelial cells (ECs), we investigated whether EC-derived EVs could regulate hematopoietic stem cell regeneration after ionizing radiation. METHODS AND MATERIALS: We generated EVs derived from primary murine marrow ECs. We sought to determine the response of irradiated hematopoietic stem and progenitor cells to syngeneic or allogeneic EVs in culture assays. Starting 24 hours after either sublethal or lethal irradiation, mice were treated with EVs or saline or cultured primary marrow endothelial cells to determine the hematopoietic response in vivo.

resultsWe demonstrate that EVs bear nuclear material and express EC-specific markers. Treatment with EVs promoted cell expansion and increased the number of colony-forming units compared to irradiated, hematopoietic cell cultures treated with cytokines alone. After total body irradiation, EV-treated mice displayed preserved marrow cellularity, marrow vessel integrity, and prolonged overall survival compared with controls treated with saline. Treatment of irradiated hematopoietic stem/progenitor cells (HSPCs) with EVs from different genetic strains showed results similar to treatment of HSPCs from syngeneic EVs. Mechanistically, treatment of irradiated HSPCs with EVs resulted in decreased levels of annexin V+ apoptotic cell death, which is mediated in part by tissue inhibitor of metalloproteinase-1.

conclusionsOur findings show that syngeneic or allogeneic EVs could serve as cell-derived therapy to deliver physiologic doses of nucleic acids and growth factors to hematopoietic cells to accelerate hematopoietic regeneration.

Indexed as

Endothelial CellsExtracellular VesiclesRegenerationAnimalsAnnexin A5ApoptosisCell CommunicationCell ProliferationCell SurvivalHematopoietic Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred BALB CMice, Inbred C57BLRadiation InjuriesTissue Inhibitor of Metalloproteinase-1Annexin A5Timp1 protein, mouseTissue Inhibitor of Metalloproteinase-1

Identifiers

PMID30763662
PMCPMC6800133
OpenAlexW2911330834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.